Treatment of Myelodysplastic Syndromes with AML-Type Chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Myelodysplastic Syndromes with AML-Type Chemotherapy

Published:1993-01 Issue:sup2 Volume:11 Page:59-63
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Estey E.,Pierce S.,Kantarjian H.,O'brien S.,Beran M.,Andreeff M.,Escudier S.,Koller C.,Kornblau S.,Robertson L.,Keating M.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199309064263

Reference15 articles.

2. Proposals for the classification of the myelodysplastic syndromes

3. Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous Leukemia

4. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications;Journal of Hematology & Oncology;2016-04-16

2. Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System;European Journal of Cancer;2016-03

3. De novoacute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study;American Journal of Hematology;2014-07-31

4. The classification of MDS: From FAB to WHO and beyond;Leukemia Research;2012-12

5. Morphologic classifications of myelodysplastic syndromes: French–American–British (FAB) and World Health Organization (WHO);Myelodysplastic Syndromes;2005-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3